Citigroup
CAMP icon

Citigroup’s CAMP4 Therapeutics CAMP Stock Holding History

Citigroup’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.4K Buy
14,975
+5,088
+51% +$21.9K ﹤0.01% 4887
2026
Q1 		$43.6K Sell
9,887
-11,516
-54% -$54.7K ﹤0.01% 4574
2025
Q4 		$131K Buy
+21,403
New +$91K ﹤0.01% 4195
2025
Q2 		– Sell
-5,008
Closed -$20K – 5669
2025
Q1 		$20K Sell
5,008
-432
-8% -$2.09K ﹤0.01% 5092
2024
Q4 		$28.4K Buy
+5,440
New +$44.7K ﹤0.01% 5217

Other funds holding CAMP

JT
Jupiter Topco New York $245B AUM
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citigroup's CAMP Position: Q2 2026 in Review

Citigroup increased its CAMP4 Therapeutics (CAMP) stake by 51% in Q2 2026, buying an estimated $21.9K and bringing the position to 14,975 shares worth $65.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4887.

Citigroup first reported a position in CAMP in Q4 2024 and has held it in 5 quarters since. The position peaked at $131K in Q4 2025. 61 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Citigroup held 14,975 shares of CAMP4 Therapeutics worth $65.4K as of Q2 2026.
  • Citigroup bought 5,088 CAMP4 Therapeutics shares in Q2 2026, an estimated $21.9K.
  • CAMP4 Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4887 holding.
  • Citigroup first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Citigroup's CAMP4 Therapeutics position peaked at $131K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.